Hybrid artificial liver using hepatocyte organoid culture

Artificial Organs

Volumn 25, Issue 3, 2001, Pages 194-200

  Funatsu, Kazumori ^a,c   Ijima, Hiroyuki ^a   Nakazawa, Kohji ^a   Yamashita, Yo Ichi ^b   Shimada, Mitsuo ^b   Sugimachi, Keizo ^b  

^a Department of Pathology   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatocyte organoid; Hollow fiber; Hybrid artificial liver support system; Polyurethane foam; Preclinical experiment; Spheroid

Indexed keywords

ARTIFICIAL ORGANS; CENTRIFUGATION; FIBERS; PACKED BEDS; RIGID FOAMED PLASTICS;

ARTIFICIAL LIVER; ARTIFICIAL LIVER SUPPORT SYSTEMS; HEPATOCYTE ORGANOID; HEPATOCYTES; HOLLOW FIBER; HYBRID ARTIFICIAL LIVER SUPPORT SYSTEM; ORGANOIDS; POLYURETHANE FOAM; PRECLINICAL EXPERIMENT; SPHEROID;

POLYURETHANES;

POLYURETHAN FOAM;

ARTICLE; ARTIFICIAL LIVER; CELL CULTURE; CENTRIFUGATION; HUMAN; IN VITRO STUDY; INOCULATION; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER SINUSOID; NONHUMAN; PRIORITY JOURNAL; SWINE; TREATMENT OUTCOME;

EID: 0034854301     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2001.025003194.x     Document Type: Article

References (44)

1. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites
2. Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure
3. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support
4. Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: The biologic-DTPF system
5. Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model
6. Characterization and evaluation of detoxification functions of a nontumorigenic immortalized porcine hepatocyte cell line (HepLiu)
7. The hepatix extracorporeal liver assist device: Initial clinical experience
8. Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical trial
9. Hemodynamic effects of therapy with a hybrid liver support system
10. Continued high albumin production by multicellular spheroids of adult rat hepatocytes formed in the presence of liver-derived proteoglycans
11. Long-term culture of adult rat hepatocyte spheroids
12. Morphological and immuno-cytochemical characterization of a hetero-spheroid composed of fibroblasts and hepatocytes
13. Spheroid formation of hepatocytes using synthetic polymer
14. Large-scale preparation and function of porcine hepatocyte spheroids
15. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells
16. Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems: Electron microscopy studies
17. Reversal of fulminant hepatic failure using an extracorporeal liver assist device
18. Development of a bioartificial liver employing xenogeneic hepatocytes
19. Novel bioartificial liver support system (BLSS): Clinical experience
20. Comparisons of porcine hepatocyte spheroids and single hepatocytes in the non-woven fabric bioartificial liver module
21. Semipermeable hollow fiber membranes in hepatocyte bioreactors: A prerequisite for a successful bioartificial liver?
22. Artificial liver support: State of the art
23. Cell-based therapy of acute liver failure: The extracorporeal bioartificial liver
24. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers
25. A novel bioreactor design for in vivo reconstruction of in vivo liver characteristics
26. High albumin production by multicellular spheroids of adult rat hepatocytes formed in the pores of polyurethane foam
27. Formation of a spherical multicellular aggregate (spheroid) of animal cells in the pores of polyurethane foam as a cell culture substratum and its application to a hybrid artificial liver
28. Hepatocyte spheroids in polyurethane foams: Functional analysis and application for a hybrid artificial liver
29. Formation of porcine hepatocyte spherical multicellular aggregates (spheroid) and analysis of drug metabolic functions
30. The formation of a spheroid of primary hepatocytes and the expression of liver-specific functions depend on the characteristics of polyurethane foam
31. Intensive promotion of spheroid formation by soluble factors in hepatocyte-condition medium
32. Tissue plasminogen activator (t-PA) production by a high density culture of weakly adherent human embryonic kidney cells using a polyurethane-foam packed-bed culture system
33. Development of a hybrid artificial liver using multi- capillary PUF/spheroid packed bed
34. Investigation of optimum culture condition for hybrid artificial liver module using PUF/porcine hepatocyte spheroid culture
35. Evaluation of a hybrid artificial liver using a polyurethane foam packed-bed culture system in dogs
36. Development of a hybrid artificial liver using a polyurethane foam/hepatocyte-spheroid packed-bed
37. Conditions required for a hybrid artificial liver support system using a PUF/hepatocyte-spheroid packed-bed module and its use in dogs with liver failure
38. Development of hybrid artificial liver support system using spheroid culture and application to warm ischemic liver failure in dog and pig as a preclinical test
39. Preclinical animal experiment of a hybrid artificial liver
40. Infection of human cells by an endogenous retrovirus of pigs
41. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue
42. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system
43. Modulation of immunologic reactions between cultured porcine hepatocytes and human sera